
Study Period | 2019 - 2030 |
Base Year For Estimation | 2024 |
Forecast Data Period | 2025 - 2030 |
Historical Data Period | 2019 - 2023 |
Market Size (2025) | USD 693.90 Million |
Market Size (2030) | USD 857.71 Million |
CAGR (2025 - 2030) | 4.33 % |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Saudi Arabia Diabetes Care Devices Market Analysis
The Saudi Arabia Diabetes Care Devices Market size is estimated at USD 693.90 million in 2025, and is expected to reach USD 857.71 million by 2030, at a CAGR of 4.33% during the forecast period (2025-2030).
The Saudi Arabian diabetes care devices landscape is experiencing significant transformation driven by technological advancements and healthcare modernization initiatives. Smart diabetes management systems, including mobile-enabled continuous glucose monitoring (CGM) devices and smartphone-integrated glucometers, are becoming increasingly prevalent in the market. The integration of artificial intelligence and data analytics in diabetes management has enabled more precise and personalized treatment approaches. According to recent healthcare statistics, the diabetic population in Saudi Arabia is growing at an alarming CAGR of 7.88%, highlighting the critical need for advanced diabetes care devices solutions.
The Saudi government has implemented comprehensive healthcare reforms aimed at combating the rising diabetes epidemic. These initiatives include the introduction of innovative preventative care programs, enhanced healthcare infrastructure, and improved access to advanced diabetes management technologies. The government has set an ambitious target to reduce diabetes prevalence by 10% over the next decade through various interventions, including fitness initiatives and preventative care programs. These reforms have been complemented by increased awareness campaigns and educational programs focusing on early detection and management of diabetes.
The market is witnessing a significant shift towards advanced insulin delivery devices and monitoring devices. Recent studies from the Saudi Scientific Diabetes Society indicate that approximately 52% of Type-2 diabetics in the country die from cardiovascular complications, driving the demand for more efficient monitoring and management solutions. This has led to increased adoption of continuous glucose monitoring systems and insulin pump technologies that offer real-time tracking and automated insulin delivery. The integration of these devices with mobile applications and cloud-based platforms has revolutionized diabetes care by enabling remote monitoring and data-driven treatment decisions.
Patient compliance and treatment adherence have shown remarkable improvement with the adoption of modern diabetes care devices. Recent healthcare data indicates a significant increase in medication compliance rates, with the percentage of patients maintaining consistent medication schedules rising to 92.7%, compared to previous rates of 70.7%. This improvement is largely attributed to the introduction of user-friendly devices, automated reminder systems, and integrated healthcare platforms that facilitate better disease management. The market has also seen growing emphasis on personalized diabetes care solutions, with manufacturers developing devices that cater to specific patient needs and lifestyle requirements.
Saudi Arabia Diabetes Care Devices Market Trends
Rising Prevalence of Diabetes in Saudi Arabia
The dramatic increase in diabetes prevalence across Saudi Arabia has emerged as a critical driver for the diabetes management devices market. The country currently ranks among the top 10 nations globally in terms of diabetes prevalence, with approximately 13.4% of the population aged 15 and older affected by diabetes mellitus. This significant health challenge has led to the establishment of the Saudi National Diabetes Center (SNDC), which has pioneered a strategic plan for comprehensive diabetes care in the Kingdom. The SNDC's approach includes creating regional diabetes management guidelines and implementing regular evaluation protocols to enhance treatment effectiveness across the Saudi population.
The rising prevalence can be attributed to several lifestyle factors deeply embedded in Saudi culture. The predominant work culture in the country, characterized by extended periods of sedentary behavior and high consumption of calorie-dense foods, has significantly contributed to increased visceral fat and central obesity. The combination of physical inactivity and dietary habits high in fats and sugars has created an environment conducive to diabetes development, particularly among the working-age population. This growing health crisis has created an urgent need for reliable diabetes devices, driving market expansion and innovation in monitoring and management solutions.
Government Initiatives and Healthcare Reforms
The Saudi Arabian government's proactive approach to combating diabetes has become a significant market driver for diabetes devices. The administration has set an ambitious target to reduce diabetes prevalence by 10% over the next decade, implementing a comprehensive strategy that includes various preventive measures and healthcare reforms. These initiatives encompass the introduction of taxes on sugary beverages, the promotion of fitness programs, and an increased focus on preventative care measures. The establishment of the Saudi National Diabetes Center (SNDC) further demonstrates the government's commitment to addressing this health challenge through structured, long-term solutions.
The healthcare system's transformation is supported by robust regulatory frameworks overseen by the Saudi Food and Drug Authority (SFDA), which governs the production, importation, marketing, and distribution of medical devices in Saudi Arabia. The SFDA has implemented detailed legislation and guidance notes specifically for the medical device sector, ensuring high-quality standards while facilitating market access for innovative diabetes management devices. This supportive regulatory environment, combined with the population's high purchasing power and the government's focus on healthcare improvement, has created favorable conditions for market growth in diabetes care devices.
Technological Advancements in Monitoring Devices
The continuous evolution of diabetes monitoring technology has emerged as a crucial driver for market growth in Saudi Arabia. The introduction of advanced continuous glucose monitoring (CGM) devices has revolutionized diabetes management by providing more accurate and comprehensive blood glucose pattern analysis compared to traditional monitoring methods. These sophisticated devices offer real-time glucose tracking and pattern recognition capabilities, enabling healthcare providers and patients to make more informed decisions about diabetes management. The recent approval of non-invasive glucose meters represents a significant technological breakthrough that has further accelerated market growth.
The integration of smart features and connectivity options in modern diabetes care devices has substantially enhanced their utility and appeal. Contemporary monitoring systems now offer capabilities such as smartphone connectivity, data analysis, and remote monitoring features, making them increasingly attractive to both healthcare providers and patients. The development of more user-friendly interfaces and improved accuracy in glucose measurement has significantly enhanced patient compliance and treatment effectiveness. These technological improvements, coupled with the growing acceptance of digital diabetes devices in Saudi Arabia, have created a strong foundation for sustained market growth in the diabetes care devices sector.
Segment Analysis: By Product
Monitoring Devices Segment in Saudi Arabia Diabetes Care Devices Market
The Continuous Glucose Monitoring (CGM) devices segment has emerged as the dominant force in the Saudi Arabia diabetes care devices monitoring market, commanding approximately 53% of the total market share in 2024. This significant market position is driven by the increasing adoption of advanced diabetes management technologies in Saudi Arabia, particularly among Type-1 diabetes patients who require constant glucose monitoring. The segment's growth is further supported by technological advancements in CGM devices, including improved sensor accuracy, longer sensor wear time, and enhanced connectivity features with smartphones and other digital health platforms. The Saudi government's initiatives to combat diabetes and the higher purchasing power of the population have also contributed to the strong market position of CGM devices in the country.

CGM Devices Segment in Saudi Arabia Diabetes Care Devices Market
The Continuous Glucose Monitoring (CGM) devices segment is experiencing remarkable growth in the Saudi Arabian market, with an expected growth rate of approximately 17% during the forecast period 2024-2029. This exceptional growth is attributed to several factors, including the increasing preference for real-time glucose monitoring systems, rising awareness about the benefits of continuous monitoring, and the integration of advanced features like mobile connectivity and automated insulin delivery systems. The segment's growth is further bolstered by ongoing innovations in sensor technology, including improved durability and accuracy, as well as the development of implantable glucose sensors that can remain in place for extended periods. The strong healthcare infrastructure in Saudi Arabia and the growing focus on preventative care are also contributing to the segment's rapid expansion.
Remaining Segments in Monitoring Devices Market
The Self-Monitoring Blood Glucose (SMBG) devices segment continues to play a crucial role in the Saudi Arabia diabetes care devices market, offering essential monitoring solutions for diabetes management. This segment includes blood glucose monitoring devices such as glucometer devices, test strips, and lancets, providing cost-effective and reliable blood glucose monitoring options for patients. The SMBG segment maintains its significance due to its widespread accessibility, ease of use, and established presence in both clinical and home care settings. The segment's stability is supported by the continued demand for basic glucose monitoring solutions, particularly among Type-2 diabetes patients who may not require continuous monitoring, and its importance in regular diabetes management protocols prescribed by healthcare providers.
Saudi Arabia Diabetes Care Devices Industry Overview
Top Companies in Saudi Arabia Diabetes Care Devices Market
The Saudi Arabian diabetes care devices market features prominent global players like Medtronic, Roche, Abbott, Dexcom, and Novo Nordisk leading the innovation landscape. These companies are actively investing in research and development to introduce advanced monitoring and management solutions, particularly focusing on continuous glucose monitoring systems and smart insulin delivery devices. Strategic partnerships with local distributors and healthcare providers have become increasingly important for market penetration and expansion. Companies are emphasizing the development of connected devices and data management platforms to enhance patient care outcomes. The market is witnessing a shift towards integrated diabetes management devices that combine devices with digital health capabilities. Operational agility is demonstrated through rapid product launches and adaptable distribution networks, while expansion strategies focus on strengthening presence in both public and private healthcare sectors.
Consolidated Market with Strong Global Players
The Saudi Arabian diabetes devices market exhibits a consolidated structure dominated by multinational corporations with established global presence. These companies leverage their extensive research capabilities, manufacturing expertise, and brand recognition to maintain market leadership. Local distribution partnerships play a crucial role in market dynamics, with companies like VitalAire Arabia securing exclusive distribution rights for advanced products such as Dexcom's CGM systems. The market has witnessed strategic collaborations between international manufacturers and local healthcare providers to enhance product accessibility and after-sales support. The presence of comprehensive quality management systems and regulatory frameworks has created high entry barriers, further strengthening the position of established players.
The market demonstrates active merger and acquisition activities, primarily driven by global players seeking to expand their product portfolios and strengthen their market presence. Companies are increasingly focusing on vertical integration strategies to control the entire value chain from manufacturing to distribution. The competitive landscape is characterized by long-term partnerships between manufacturers and healthcare institutions, creating stable market relationships. Market players are investing in local infrastructure and support services to enhance their competitive position and meet the growing demand for diabetes care devices.
Innovation and Integration Drive Market Success
Success in the Saudi Arabian diabetes care devices market increasingly depends on companies' ability to offer integrated solutions that combine innovative devices with comprehensive support services. Market incumbents are focusing on developing connected devices that enable seamless data sharing between patients and healthcare providers. The adoption of artificial intelligence and machine learning capabilities in diabetes management devices is becoming a key differentiator. Companies are investing in patient education programs and healthcare provider training to build brand loyalty and market presence. The establishment of local manufacturing facilities and research centers is emerging as a strategic priority to enhance market responsiveness and reduce operational costs.
For new entrants and emerging players, success lies in identifying and addressing specific market gaps while building strong distribution networks. Companies need to navigate the complex regulatory environment while maintaining product quality and compliance with international standards. The development of cost-effective solutions without compromising on technological advancement is crucial for market penetration. Strategic partnerships with established healthcare providers and insurance companies can provide competitive advantages. The market's future will be shaped by the ability to adapt to changing healthcare policies, technological advancements, and evolving patient needs while maintaining operational efficiency and service quality.
Saudi Arabia Diabetes Care Devices Market Leaders
-
Becton Dickinson
-
F. Hoffmann-La Roche AG
-
Medtronic plc
-
DexCom, Inc.
-
Abbott Laboratories
- *Disclaimer: Major Players sorted in no particular order

Saudi Arabia Diabetes Care Devices Market News
- July 2022: Under Vision 2030, the Saudi Arabian government plans to invest over USD 65 billion to develop the country's healthcare infrastructure. In addition, it aimed to increase the private sector's contribution from 40 percent to 65 percent by 2030, targeting the privatization of 290 hospitals and 2,300 primary health centers.
- May 2022: Tamer, the Middle East's healthcare distribution company, has agreed on a 5-year deal to bring Huma's technology platform to power 'hospitals at home' with remote patient monitoring to the 34 million people living in the Kingdom of Saudi Arabia. The new health program was to begin with support for patients with diabetes and cardiovascular disease.
Saudi Arabia Diabetes Care Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Drivers
- 4.3 Restraints
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Monitoring Devices
- 5.1.1 Self-Monitoring Blood Glucose Devices
- 5.1.1.1 Glucometer Devices
- 5.1.1.2 Blood Glucose Test Strips
- 5.1.1.3 Lancets
- 5.1.2 Continuous Glucose Monitoring Devices
- 5.1.2.1 Sensors
- 5.1.2.2 Durables (Receivers and Transmitters)
-
5.2 Management Devices
- 5.2.1 Insulin Delivery Devices
- 5.2.1.1 Insulin Pump Devices
- 5.2.1.1.1 Insulin Pump Monitors
- 5.2.1.1.2 Insulin Pump Reserviors
- 5.2.1.1.3 Insulin Infusion Sets
- 5.2.1.2 Insulin Syringes
- 5.2.1.3 Insulin Disposable Pens
- 5.2.1.4 Insulin Cartridges in Reusable Pens
- 5.2.1.5 Jet Injectors
6. MARKET INDICATORS
- 6.1 Type - 1 Diabetes Population
- 6.2 Type - 2 Diabetes Population
7. COMPETITIVE LANDSCAPE
-
7.1 Company Profiles
- 7.1.1 Abbott Diabetes Care
- 7.1.2 F. Hoffmann-La Roche Ltd.
- 7.1.3 Johnson & Johnson (LifeScan)
- 7.1.4 Arkray
- 7.1.5 Ascensia Diabetes Care
- 7.1.6 Sanofi
- 7.1.7 Dexcom Inc.
- 7.1.8 Medtronic
- 7.1.9 Novo Nordisk AS
- 7.1.10 Becton Dickinson
- 7.1.11 Eli Lilly
- 7.1.12 Ypsomed Holding AG
- 7.1.13 Terumo
- *List Not Exhaustive
- 7.2 Company Share Analysis
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
Saudi Arabia Diabetes Care Devices Industry Segmentation
Blood glucose monitors, continuous glucose monitors, insulin pumps, smart insulin pens, and diabetes management software are some of the several types of equipment that may track diabetic symptoms. Devices for measuring glucose enhance patients' health by helping to maintain and manage their blood sugar levels. The Saudi Arabian diabetes care devices market is segmented into monitoring devices (self-monitoring blood glucose devices and continuous glucose monitoring devices) and management devices (insulin delivery devices, insulin syringes, disposable insulin pens, insulin cartridges in reusable pens, and jet injectors). The report offers market sizes and forecasts for value (USD million) and volume (in units) for the above segments.
Monitoring Devices | Self-Monitoring Blood Glucose Devices | Glucometer Devices | ||
Blood Glucose Test Strips | ||||
Lancets | ||||
Continuous Glucose Monitoring Devices | Sensors | |||
Durables (Receivers and Transmitters) | ||||
Management Devices | Insulin Delivery Devices | Insulin Pump Devices | Insulin Pump Monitors | |
Insulin Pump Reserviors | ||||
Insulin Infusion Sets | ||||
Insulin Syringes | ||||
Insulin Disposable Pens | ||||
Insulin Cartridges in Reusable Pens | ||||
Jet Injectors |
Saudi Arabia Diabetes Care Devices Market Research FAQs
How big is the Saudi Arabia Diabetes Care Devices Market?
The Saudi Arabia Diabetes Care Devices Market size is expected to reach USD 693.90 million in 2025 and grow at a CAGR of 4.33% to reach USD 857.71 million by 2030.
What is the current Saudi Arabia Diabetes Care Devices Market size?
In 2025, the Saudi Arabia Diabetes Care Devices Market size is expected to reach USD 693.90 million.
Who are the key players in Saudi Arabia Diabetes Care Devices Market?
Becton Dickinson, F. Hoffmann-La Roche AG, Medtronic plc, DexCom, Inc. and Abbott Laboratories are the major companies operating in the Saudi Arabia Diabetes Care Devices Market.
What years does this Saudi Arabia Diabetes Care Devices Market cover, and what was the market size in 2024?
In 2024, the Saudi Arabia Diabetes Care Devices Market size was estimated at USD 663.85 million. The report covers the Saudi Arabia Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Saudi Arabia Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Saudi Arabia Diabetes Care Devices Market Research
Mordor Intelligence provides a comprehensive analysis of the diabetes care devices industry. This report offers detailed insights into the rapidly evolving continuous glucose monitoring (CGM) sector. Our extensive research covers the full range of diabetes monitoring system technologies. This includes blood glucose monitoring devices, insulin pump technologies, and diabetes lancet products. The report delivers a thorough analysis of CGM devices adoption trends and the growing integration of digital diabetes devices in healthcare settings. We place particular focus on emerging diabetes wearable devices technologies.
Stakeholders can download our report PDF to access in-depth analysis of insulin delivery devices innovations. This includes advanced insulin pen systems and revolutionary artificial pancreas developments. The research examines the shift toward smart diabetes management solutions. It provides strategic insights into diabetes testing devices market dynamics. Our analysis covers the latest developments in diabetes management devices, offering valuable data for healthcare providers, manufacturers, and investors. This information is crucial for those looking to understand the evolving landscape of diabetes care technology in Saudi Arabia.